Pharmaceutical Industry South Africa

Home > Report Group > Pharmaceutical Industry South Africa

Checkout

The Pharmaceutical Industry in South Africa 2023

Gary Phillips | South Africa | 23 August 2023

The Pharmaceutical Industry in South Africa 2022

Carole Veitch | South Africa | 08 March 2022

The Pharmaceutical Industry in South Africa 2020

Carole Veitch | South Africa | 11 December 2020

The Pharmaceutical Industry in South Africa 2019

Ebhrahim Khalil | South Africa | 05 April 2019

The Pharmaceutical Industry in South Africa 2017

Ebrahim-Khalil Hassen | South Africa | 08 December 2017

The Pharmaceutical Industry in South Africa 2016

Ebrahim-Khalil Hassen | South Africa | 12 September 2016

The Pharmaceutical Industry in South Africa 2014

Amanda van der Westhuizen | South Africa | 30 May 2014

Report Coverage

This report on the pharmaceutical industry in South Africa provides comprehensive information on the manufacturing, wholesale and retail subsectors, price regulation, medical cannabis, market shares, notable multinational and local players and corporate actions. There are profiles of 128 companies including local dominant players Aspen Pharmacare and Adcock Ingram, multinationals such as Bayer, GlaxoSmithKline and Pfizer and retailers Clicks and Dis-Chem and other players such as Nativa.

Introduction

• More than 80% of South African pharmaceutical manufacturing and distribution revenue is from the private sector. \r\n
• State purchases of pharmaceuticals are declining, and manufacturers’ margins are under pressure due to low regulated price increases for scheduled pharmaceuticals in a high inflation environment. \r\n
• In the retail sector Clicks and Dis-Chem have wholesale volume advantages and an ever-increasing footprint. \r\n
• Consumer spending patterns have forced consolidation in the retail sector, the growth of private label sales, growth in convenience formats, and diversification into new services and products. \r\n
• There has been a flurry of investments in localising vaccine raw material and finished dose manufacturing, although the sustainability of these initiatives is far from secure.

Trends

• A shift from reactive medicine to preventative healthcare resulting in demand for immunity-building vitamins, tonics, minerals and supplements.
• Focus on research and development, particularly drugs and therapies targeting COVID-19, HIV/Aids, TB, malaria, cancer, and chronic diseases.
• Growing pressure on pharmaceutical companies to improve access to healthcare by making medicines more affordable.
• Increased focus on localisation, including local sourcing of inputs and the development of local manufacturing capacity.
• Recovery of demand as elective surgery and procedures and illnesses such as flu return to pre-pandemic patterns.
• Small community pharmacies are finding it difficult to compete with large retail businesses.

Opportunities

• Cannabis cultivation, processing and medical product manufacturing.
• Rapid growth in generic sales making medicine more affordable.
• Strong R&D and advanced manufacturing capabilities may attract investment-.

Challenges

• Growing concentration of wholesale and retail pharmacy supply.
• Low regulated medicine price increases in the context of high international inflation.
• Poor economic growth constraining consumer spending on healthcare.
• Reduced government budgets for medicines restricting local opportunities in the face of cheaper international competition.
• South Africa’s dependence on imported active ingredients.
• Sustaining local vaccine manufacturing in the face of declining demand.

Outlook

• The pharmaceutical industry is well developed and supported by strong R&D and advanced manufacturing capabilities, including biotechnology manufacturing facilities. \r\n
• The Department of Health’s affordable medicines programme has been instrumental in lowering scheduled pharmaceutical prices, particularly in the public sector. \r\n
• Investments in vaccine manufacture have begun to address South Africa’s exposure to vulnerabilities and dependence on active pharmaceutical ingredient and vaccine imports.\r\n
• These investments have strengthened South Africa’s position as the hub for sub-Saharan African pharmaceutical research, development, and supply. \r\n
• However, vaccine demand has dropped and doses are being donated to African countries. \r\n
• Margin pressure is expected to grow as the economy remains poor and restraints on consumer spending intensify. \r\n
• The implementation of the National Health Insurance is likely to put further pressure on manufacturers and wholesalers to reduce medicine prices.

The Pharmaceutical Industry in South Africa 2023

Full Report

R 9 500.00(ZAR) estimated $525.29 (USD)*

Buy Now +

Industry Landscape

R 6 650.00(ZAR) estimated $ 367.70 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Value Chain	9
2.2.	Geographic Position	10
2.3.	Size of the Industry	11
3.	LOCAL	17
3.1.	State of the Industry	17
3.2.	Key Trends	22
3.3.	Key Issues	23
3.4.	Notable Players	24
3.5.	Trade	34
3.6.	Corporate Actions	36
3.7.	Regulations	38
3.8.	Enterprise Development and Social Development	43
4.	AFRICA	45
5.	INTERNATIONAL	50
6.	INFLUENCING FACTORS	57
6.1.	Unforeseen Events	57
6.2.	Economic Environment	58
6.3.	Labour	60
6.4.	Environmental Issues	62
6.5.	Technology, R&D, Innovation	63
6.6.	Government Support	65
6.7.	Input Costs	67
6.8.	Drug Abuse and Other Health Concerns	68
7.	COMPETITIVE ENVIRONMENT	68
7.1.	Competition	68
7.2.	Ownership Structure of the Industry	70
7.3.	Barriers to Entry	70
8.	INDUSTRY SUMMARY	71
9.	OUTLOOK	72
10.	INDUSTRY ASSOCIATIONS	72
11.	REFERENCES	73
11.1.	Publications	73
11.2.	Websites	74
	APPENDIX 1	75
	Summary of Notable Players	75
	COMPANY PROFILES	89
	Abbott Laboratories South Africa (Pty) Ltd	89
	Acino Healthcare Group (Pty) Ltd	91
	Adcock Ingram Holdings Ltd	93
	African Medicines (Pty) Ltd	98
	Afrigen Biologics (Pty) Ltd	100
	Afriplex (Pty) Ltd	102
	AIM Africa	105
	Alpha Pharm (Pty) Ltd	107
	Amka Products (Pty) Ltd	109
	Amway South Africa (Pty) Ltd	112
	Arrie Nel Pharmacy Group (Pty) Ltd	114
	Ascendis Health Ltd	116
	Aspen Pharmacare Holdings Ltd	121
	Astellas Pharma (Pty) Ltd	127
	AstraZeneca Pharmaceuticals (Pty) Ltd	129
	Aurobindo Pharma (Pty) Ltd	131
	Austell Pharmaceuticals (Pty) Ltd	133
	B Braun Medical (Pty) Ltd	135
	Barrs Pharmaceuticals Industries (Pty) Ltd	138
	Baxter Healthcare South Africa (Pty) Ltd	140
	Bayer (Pty) Ltd	142
	Becton Dickinson (Pty) Ltd	145
	Bio Earth Manufacturing (Pty) Ltd	147
	Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The)	149
	Bitek Industries (Pty) Ltd	151
	California Pharmaceuticals (Pty) Ltd	153
	Caprichem (Pty) Ltd	155
	Chemical Convertors (Pty) Ltd	157
	Chemtron Holdings (Pty) Ltd	158
	Cilo Cybin Pharmaceutical (Pty) Ltd	160
	Cipla Medpro South Africa (Pty) Ltd	162
	Columbia Pharmaceuticals (Pty) Ltd	165
	CoMED Health (Pty) Ltd	167
	Deon Schoeman CC	169
	Dis-Chem Pharmacies Ltd	172
	Dr Reddy\'s Laboratories (Pty) Ltd	184
	DSV Solutions (Pty) Ltd	186
	Dynachem (Pty) Ltd	188
	Ecolab (Pty) Ltd	190
	Eli Lilly (S A) (Pty) Ltd	192
	Evohealth (Pty) Ltd	194
	Felbridge (Pty) Ltd	196
	Ferring (Pty) Ltd	198
	Forever Living Products South Africa (Pty) Ltd	200
	Fresenius Kabi Manufacturing SA (Pty) Ltd	203
	Fresenius Kabi South Africa (Pty) Ltd	205
	G M Pharmaceuticals (Pty) Ltd	208
	GlaxoSmithKline South Africa (Pty) Ltd	210
	Glenmark Pharmaceuticals South Africa (Pty) Ltd	213
	Goodleaf Company (Pty) Ltd (The)	215
	Gulf Drug Company (Pty) Ltd	217
	H H Durrheim (Pty) Ltd	219
	Herba Zone (Pty) Ltd	221
	Herbalife International South Africa Ltd	223
	Hersol Manufacturing Laboratories (Pty) Ltd	225
	Hymed (Pty) Ltd	227
	IMBC Investment (Pty) Ltd	229
	iMvula Healthcare Logistics (Pty) Ltd	231
	Infection Protection Products (Pty) Ltd	233
	Ingelheim Pharmaceuticals (Pty) Ltd	235
	Iszipharm Pharmaceutical Distributors (Pty) Ltd	237
	Joe Soap CC	239
	Johnson and Johnson (Pty) Ltd	241
	Kellogg Company of South Africa (Pty) Ltd	243
	Kevali Chemical Group (Pty) Ltd	245
	Lakato (Pty) Ltd	247
	Leaf Botanicals (Pty) Ltd	249
	MedCan (Pty) Ltd	250
	Medichem (Pty) Ltd	251
	Mega Magic CC	252
	Merck (Pty) Ltd	254
	MSD (Pty) Ltd	256
	National Bioproducts Institute NPC	258
	Nativa (Pty) Ltd	260
	NeoLife International (Pty) Ltd	262
	Nestle (South Africa) (Pty) Ltd	264
	Netcare Pharmacies (Pty) Ltd	268
	Netcare Pharmacies 2 (Pty) Ltd	270
	New Clicks South Africa (Pty) Ltd	272
	Nkunzi Pharmaceuticals (Pty) Ltd	276
	Novartis South Africa (Pty) Ltd	278
	Omnia Holdings Ltd	280
	Organon South Africa (Pty) Ltd	286
	P and G South African Trading (Pty) Ltd	288
	Parceval (Pty) Ltd	290
	Pfizer Laboratories (Pty) Ltd	292
	Pharma Dynamics (Pty) Ltd	295
	Pharmaceutical Enterprises (Pty) Ltd	297
	Pharmacy Direct (Pty) Ltd	299
	Pharmacyweb Holdings (Pty) Ltd	301
	PharmaForce (Pty) Ltd	302
	Pharmed Pharmaceuticals (Pty) Ltd	304
	Pick n Pay Stores Ltd	306
	Platchem (Pty) Ltd	311
	Prime Cleaning Suppliers (Pty) Ltd	312
	Ranbaxy (S A) (Pty) Ltd	314
	Ranbaxy Pharmaceuticals (Pty) Ltd	316
	Reckitt Benckiser Pharmaceuticals (Pty) Ltd	318
	Releaf Pharmaceuticals (Pty) Ltd	320
	Richbay Chemicals (Pty) Ltd	322
	Roche Products (Pty) Ltd	324
	S A F I C (Pty) Ltd	327
	S A Natural Products (Pty) Ltd	329
	S Buys (Pty) Ltd	331
	Safarmex (Pty) Ltd	334
	Safety Chemicals (Pty) Ltd	336
	Sandoz South Africa (Pty) Ltd	337
	Sanofi Industries South Africa (Pty) Ltd	339
	Sanofi-Aventis South Africa (Pty) Ltd	341
	Shoprite Holdings Ltd	344
	Solgar South Africa (Pty) Ltd	349
	Sonke Pharmaceuticals (Pty) Ltd	351
	South African Nuclear Energy Corporation SOC Ltd (The)	353
	SPAR Group Ltd (The)	357
	Specialised Maintenance Products (Pty) Ltd	362
	Specpharm Holdings (Pty) Ltd	363
	Spectank (Pty) Ltd	365
	Tevo (Pty) Ltd	368
	Tiger Brands Ltd	370
	Topmed Health Care Distributors (Pty) Ltd	375
	Touchless Germ Control Western Cape CC	377
	Transpharm (Pty) Ltd	378
	Unilever South Africa (Pty) Ltd	380
	Viatris South Africa (Pty) Ltd	383
	Vital Health Foods (Pty) Ltd	385
	Waco Africa (Pty) Ltd	387
	Wellness Warehouse (Pty) Ltd	391
	Woolworths Holdings Ltd	395

Report Coverage

This report focuses on the pharmaceutical industry in South Africa including manufacture, retail and wholesale trade in pharmaceuticals and alternative health products, such as medicinal cannabis. The report includes information on the state and size of the industry, notable players in each subsector, developments, corporate actions, regulations and other influencing factors. There are profiles of 129 companies including international companies Cipla, Novartis, Johnson & Johnson and Pfizer, local companies including Aspen and Adcock Ingram, retailers Clicks and Dis-Chem, and cannabis companies such as Goodleaf.

Introduction

The importance of the pharmaceutical industry has been amplified by the COVID-19 pandemic and the resulting global health crisis. The sector, which generated total sales revenue of around R60.4bn in 2021, has been designated as a strategic industry as it produces and supplies essential products. South Africa has the world’s largest antiretroviral (ARV) programme and is one of the major producers of radiopharmaceuticals . With the ongoing development of local manufacturing capacity and capabilities, local pharmaceutical companies are set to play a pivotal role in the production and supply of COVID-19 vaccines and other medicines for the domestic market and the rest of Africa. \r\n\r\nThis report also examines the wholesale and retail trade in pharmaceuticals and alternative health products, such as medicinal cannabis. In 2021, government unveiled a cannabis master plan that aims to expand the country’s nascent cannabis industry, attract foreign investment and create up to 25,000 jobs. While cannabis is widely touted as a panacea, medical scientists caution that there is still a lack of reliable evidence to support claims about its medical efficacy.

Strengths

• South Africa has the largest antiretroviral (ARV) treatment programme in the world and almost half of the people infected with HIV/Aids in South Africa are on ARVs.
• South Africa is one of the world’s largest producers of radiopharmaceuticals.
• South Africa is the only Southern African Development Community member country that complies with the World Health Organisation’s Good Manufacturing Practice standards.
• The industry is supported by strong research and development capabilities and advanced manufacturing capabilities, including biotechnology manufacturing facilities.
• The presence of several of the world’s largest pharmaceutical companies supports research and product development.

Weaknesses

• Although pharmaceuticals are strictly regulated, over-the-counter medications and prescription drugs are widely misused and abused.
• Inadequate quality control of CBD products, hand sanitisers and other hygiene products.
• The cost of medicinal products, particularly newly developed treatments such as cell and gene therapies, is high.
• There are around 30 pharmacists per 100,000 people, well below the global benchmark of 50 per 100,000.
• There is an overreliance on imported active pharmaceutical ingredients and certain finished medicinal products.

Opportunities

• Advances in 3D printing have made the production of small batches of tablets viable.
• As the Department of Health expands its chronic medication delivery and collection services programme, greater collaboration between the public health sector and pharmacies is anticipated.
• Government has identified the pharmaceutical industry as a strategic sector and it supports the procurement of locally-manufactured products.
• National Health Insurance offers opportunities for private sector community
• Participation of retail pharmacies in the national vaccination programme.
• pharmacies to provide primary care services to public health patients.
• Strong demand for home delivery services is driving the expansion of courier pharmacy networks.
• The development and manufacture of active pharmaceutical ingredients.
• The development of traditional/indigenous medicines.
• The development, production and supply of health products containing cannabidiol, such as CBD oil.
• The supply of healthcare products via online and mobile retail channels.
• The supply of sanitising products and disinfectants locally and to the rest of Africa.
• With free trade between African counties underway, South Africa is aiming to expand its pharmaceutical exports into the rest of Africa.

Threats

• Climate-change related shocks.
• Counterfeit medication and substandard products pose health risks.
• Further reputational damage resulting from the misuse/abuse of prescription drugs.
• Global supply chain disruptions.
• Misinformation spread via social media and other channels about vaccinations and unproven remedies.
• New COVID-19 variants and the outbreak of other pandemics.
• Social unrest.
• Sustained economic pressures could result in funding constraints.
• The emergence of drug-resistant super bugs.

Outlook

The pandemic has brought into sharp focus the critical need for access to vaccines and affordable medicines. The gridlocked global supply chain has highlighted the risks associated with South Africa’s over-reliance on imports for active pharmaceutical ingredients and essential drugs. While stakeholders have welcomed initiatives to boost domestic manufacturing capacity and capabilities, they say that South Africa needs to reduce its dependency on imported inputs. With free trade under the African Continental Free Trade Area Agreement underway, role players anticipate that South African pharmaceutical manufacturers will perform an increasingly important role in the provision of vaccines and other pharmaceutical products to the rest of Africa.\r\n\r\nIn the retail space, analysts foresee continued expansion of ecommerce and other dispensing channels, such as pharmaceutical vending machines. Stakeholders say that the collaboration of private retail pharmacies with the Department of Health on the COVID-19 vaccination programme has proved highly successful and paves the way for future partnerships between the public and private sectors. While the pandemic presents opportunities for companies in the pharmaceutical value chain, analysts expect the operating environment to remain challenging over the medium-term. \r\n\r\nAnalysts predict that the local medical cannabis industry will expand rapidly over the next five years. While some smaller cannabis businesses have reservations about large pharmaceutical companies dominating the market, others say that the industry has been given a “shot in the arm” by government’s cannabis master plan.

The Pharmaceutical Industry in South Africa 2022

Full Report

R 6 500.00(ZAR) estimated $359.41 (USD)*

Buy Now +

Industry Landscape

R 4 550.00(ZAR) estimated $ 251.59 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Value Chain	10
2.2.	Geographic Position	11
2.4.	Key Success Factors and Pain Points	18
3.	LOCAL	19
3.1.	Key Trends	22
3.2.	Notable Players	24
3.3.	Trade	27
3.4.	Corporate Actions	32
3.5.	Regulations	34
3.6.	Enterprise Development and Social Economic Development	40
4.	AFRICA	42
5.	INTERNATIONAL	49
6.	INFLUENCING FACTORS	56
6.1.	COVID -19	56
6.2.	Economic Environment	61
6.3.	Labour	62
6.4.	Environmental Issues	66
6.5.	Technology, Research and Development (R&D) and Innovation	67
6.6.	Government Support	69
6.7.	Drug Abuse and Other Health Concerns	71
7.	COMPETITIVE ENVIRONMENT	73
7.1.	Competition	73
7.2.	Ownership Structure of the Industry	74
7.3.	Barriers to Entry	75
8.	SWOT ANALYSIS	75
9.	OUTLOOK	77
10.	INDUSTRY ASSOCIATIONS	78
11.	REFERENCES	79
11.1.	Publications	79
11.2.	Websites	80
	APPENDICES	82
	Appendix 1 - Summary of Notable Players	82
	COMPANY PROFILES	95
	Abbott Laboratories South Africa (Pty) Ltd	95
	Acino Healthcare Group (Pty) Ltd	97
	Adcock Ingram Holdings Ltd	100
	African Medicines (Pty) Ltd	105
	Afrigen Biologics (Pty) Ltd	107
	Afriplex (Pty) Ltd	109
	AIM Africa	112
	Alpha Pharm (Pty) Ltd	114
	Amka Products (Pty) Ltd	117
	Amway South Africa (Pty) Ltd	120
	Arrie Nel Pharmacy Group (Pty) Ltd	122
	Ascendis Health Ltd	124
	Aspen Pharmacare Holdings Ltd	130
	Astellas Pharma (Pty) Ltd	136
	AstraZeneca Pharmaceuticals (Pty) Ltd	138
	Aurobindo Pharma (Pty) Ltd	140
	Austell Pharmaceuticals (Pty) Ltd	142
	B Braun Medical (Pty) Ltd	144
	Barrs Pharmaceuticals Industries (Pty) Ltd	147
	Baxter Healthcare South Africa (Pty) Ltd	149
	Bayer (Pty) Ltd	151
	Becton Dickinson (Pty) Ltd	154
	Bio Earth Manufacturing (Pty) Ltd	156
	Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The)	158
	Bitek Industries (Pty) Ltd	160
	California Pharmaceuticals (Pty) Ltd	162
	Caprichem (Pty) Ltd	164
	Chemical Convertors (Pty) Ltd	167
	Chemtron Holdings (Pty) Ltd	168
	Cilo Cybin Pharmaceutical (Pty) Ltd	170
	Cipla Medpro South Africa (Pty) Ltd	172
	Columbia Pharmaceuticals (Pty) Ltd	176
	CoMED Health (Pty) Ltd	178
	Deon Schoeman CC	180
	Dis-Chem Pharmacies Ltd	182
	Dr Reddy\'s Laboratories (Pty) Ltd	193
	DSV Healthcare (Pty) Ltd	195
	Dynachem (Pty) Ltd	197
	Ecolab (Pty) Ltd	199
	Eli Lilly (S A) (Pty) Ltd	201
	Evohealth (Pty) Ltd	203
	Felbridge (Pty) Ltd	205
	Ferring (Pty) Ltd	207
	Forever Living Products South Africa (Pty) Ltd	209
	Fresenius Kabi Manufacturing SA (Pty) Ltd	212
	Fresenius Kabi South Africa (Pty) Ltd	214
	G M Pharmaceuticals (Pty) Ltd	217
	GlaxoSmithKline South Africa (Pty) Ltd	219
	Glenmark Pharmaceuticals South Africa (Pty) Ltd	222
	Goodleaf Company (Pty) Ltd (The)	224
	Gulf Drug Company (Pty) Ltd	226
	H H Durrheim (Pty) Ltd	228
	Herba Zone (Pty) Ltd	230
	Herbalife International South Africa Ltd	232
	Hersol Manufacturing Laboratories (Pty) Ltd	234
	Hymed (Pty) Ltd	236
	IMBC Investment (Pty) Ltd	238
	iMvula Healthcare Logistics (Pty) Ltd	240
	Infection Protection Products (Pty) Ltd	243
	Ingelheim Pharmaceuticals (Pty) Ltd	245
	Iszipharm Pharmaceutical Distributors (Pty) Ltd	247
	Joe Soap CC	249
	Johnson and Johnson (Pty) Ltd	251
	Kellogg Company of South Africa (Pty) Ltd	253
	Kevali Chemical Group (Pty) Ltd	255
	Lakato (Pty) Ltd	257
	Leaf Botanicals (Pty) Ltd	259
	MedCan (Pty) Ltd	260
	Medichem (Pty) Ltd	261
	Mega Magic CC	263
	Merck (Pty) Ltd	265
	MSD (Pty) Ltd	267
	National Bioproducts Institute NPC	269
	Nativa (Pty) Ltd	271
	NeoLife International (Pty) Ltd	273
	Nestle (South Africa) (Pty) Ltd	275
	Netcare Pharmacies (Pty) Ltd	279
	Netcare Pharmacies 2 (Pty) Ltd	281
	New Clicks South Africa (Pty) Ltd	283
	Nkunzi Pharmaceuticals (Pty) Ltd	286
	Novartis South Africa (Pty) Ltd	288
	Nutritional Holdings Ltd	291
	Omnia Holdings Ltd	295
	Organon South Africa (Pty) Ltd	300
	P and G South African Trading (Pty) Ltd	302
	Parceval (Pty) Ltd	304
	Pfizer Laboratories (Pty) Ltd	306
	Pharma Dynamics (Pty) Ltd	309
	Pharmaceutical Enterprises (Pty) Ltd	311
	Pharmacy Direct (Pty) Ltd	313
	Pharmacyweb Holdings (Pty) Ltd	315
	PharmaForce (Pty) Ltd	316
	Pharmed Pharmaceuticals (Pty) Ltd	318
	Pick n Pay Stores Ltd	321
	Platchem (Pty) Ltd	326
	Prime Cleaning Suppliers (Pty) Ltd	328
	Ranbaxy (S A) (Pty) Ltd	330
	Ranbaxy Pharmaceuticals (Pty) Ltd	332
	Reckitt Benckiser Pharmaceuticals (Pty) Ltd	334
	Releaf Pharmaceuticals (Pty) Ltd	336
	Richbay Chemicals (Pty) Ltd	338
	Roche Products (Pty) Ltd	341
	S A F I C (Pty) Ltd	344
	S A Natural Products (Pty) Ltd	346
	S Buys (Pty) Ltd	348
	Safarmex (Pty) Ltd	351
	Safety Chemicals (Pty) Ltd	353
	Sandoz South Africa (Pty) Ltd	355
	Sanofi Industries South Africa (Pty) Ltd	357
	Sanofi-Aventis South Africa (Pty) Ltd	359
	Shoprite Holdings Ltd	362
	Solgar South Africa (Pty) Ltd	368
	Sonke Pharmaceuticals (Pty) Ltd	370
	South African Nuclear Energy Corporation Ltd (The)	372
	SPAR Group Ltd (The)	376
	Specialised Maintenance Products (Pty) Ltd	382
	Specpharm Holdings (Pty) Ltd	383
	Spectank (Pty) Ltd	385
	Tevo (Pty) Ltd	387
	Tiger Brands Ltd	389
	Topmed Health Care Distributors (Pty) Ltd	394
	Touchless Germ Control Western Cape CC	396
	Transpharm (Pty) Ltd	397
	Unilever South Africa (Pty) Ltd	399
	Vital Health Foods (Pty) Ltd	403
	Waco Africa (Pty) Ltd	405
	Wellness Warehouse (Pty) Ltd	409
	Woolworths Holdings Ltd	413
	Xixia Pharmaceuticals (Pty) Ltd	417

Report Coverage

This report focuses on the manufacture of pharmaceuticals in South Africa and includes the wholesale and retail trade in pharmaceutical products. It includes information on the state and size of the sector and influencing factors including the response to coronavirus, regulation, research and development and competition. There are profiles of 122 companies including international companies operating in South Africa such as Cipla, Sanofi and Novartis, major local manufacturers such as Aspen and Adcock Ingram and retailers including Clicks and Dis-Chem. Other profiles include state-owned South African Nuclear Energy Corporation, whose subsidiary NTP Radioisotopes is one of the world’s largest producers of medical radioisotopes and radioisotope-based diagnostic imaging and therapy products, and Alpha Pharm pharmacies, the largest group of independent community pharmacies in South Africa.

Introduction

This report focuses on the manufacture of pharmaceuticals in South Africa and examines the wholesale and retail trade in pharmaceutical products. The domestic pharmaceutical market, which generated total revenue of approximately R56.4bn in 2019, is a supplier of essential products that improve health and save lives and has been identified by government as a strategic sector. South Africa’s antiretroviral (ARV) programme is the largest of its kind globally and the country is one of the world’s major producers of radiopharmaceuticals0F . The importance of the pharmaceutical sector has been amplified by the coronavirus pandemic, which has created an unprecedented global health crisis. South Africa produces the steroid dexamethasone, which has proved to be a game-changer in the treatment of severe coronavirus cases, and local researchers continue to play a key role in coronavirus vaccine trials. In the absence of a safe and effective vaccine, hand sanitisers and other hygiene products remain in high demand and the market continues to be flooded with products supplied by non-specialist companies.

Strengths

• About 70% of pharmaceutical products consumed in South Africa are locally produced.
• South Africa is one of the world’s largest producers of radiopharmaceuticals.
• South Africa’s HIV/Aids antiretroviral (ARV) programme is the largest of its kind in the world.
• The presence of several of the world’s largest pharmaceutical companies facilitates knowledge sharing and supports research and product development.
• The South African pharmaceutical industry is well developed and complies with World Health Organisation production standards.
• There is a high standard of research and development.

Weaknesses

• Although pharmaceuticals are strictly regulated, over-the-counter medications and prescription drugs are widely misused and abused.
• Quality control relating to hand sanitisers and other hygiene products.
• The cost of medicinal products, particularly newly developed treatments such as cell and gene therapies, is high.
• There are around 26 pharmacists per 100,000 people, well below the global benchmark of 50 per 100,000.
• There is an overreliance on imported active pharmaceutical ingredients.

Opportunities

• Advances in 3D printing have made the production of small batches of tablets viable.
• As the Department of Health expands its chronic medication delivery and collection services programme, greater collaboration between it and pharmacies is anticipated.
• Government has identified the pharmaceutical industry as a strategic sector and it supports the procurement of locally manufactured products.
• Strong demand for home delivery services is driving the expansion of courier pharmacy networks.
• The development of bio-based medicinal products using locally sourced plant-based ingredients.
• The development, production and supply of health products containing cannabidiol.
• The National Health Insurance offers opportunities for private sector community pharmacies to provide primary care services to public health patients.
• The supply of complementary (alternative) healthcare products via online and mobile retail channels.
• The supply of sanitising products and disinfectants to the domestic market and to the rest of Africa.
• With free trade between African counties set to commence in 2021, South Africa aims to expand its pharmaceutical exports into the rest of Africa.

Threats

• Climate change-related shocks.
• Counterfeit medication and substandard sanitising products pose a threat to public health and safety.
• Economic pressures could result in funding constraints.
• Further reputational damage resulting from the misuse/abuse of prescription drugs.
• The emergence of drug-resistant “super bugs”.
• The pandemic could cause further supply chain disruption.
• The resurgence of coronavirus and the emergence of new infectious diseases.

Outlook

Pandemic-related supply chain disruptions have highlighted the risks associated with South Africa’s overreliance on imported pharmaceutical inputs and certain finished medicinal products, amplifying the need for greater self-sufficiency. Role players have welcomed government’s commitment to support locally manufactured products and are optimistic that local manufacturers will be able to ramp up production to meet the needs of the country and the continent. South African-based pharmaceutical manufacturers are set to benefit from the creation of the African Continental Free Trade Area and, with free trade between African states scheduled to commence in 2021, role players are hoping to expand pharmaceutical exports into the rest of Africa. \r\n\r\nIn the wholesale and retail markets, stakeholders predict that players will continue to explore non-traditional distribution, delivery and dispensing models. Ecommerce is expected to remain on a strong growth trajectory. With private retail pharmacies already partnering with the Department of Health to dispense antiretroviral (ARV) treatment and chronic medications to state-patients, role players anticipate a higher level of collaboration between the public and private sectors going forward. In the research and development space, stakeholders are hopeful of attracting investment for the development of new treatments and hygiene products. In the interim, the quest for safe and effective coronavirus vaccines and other treatments continues. Researchers say that until such time as a reliable vaccine has been administered to the population, hand sanitisers will remain a vital aspect of the pandemic response.

The Pharmaceutical Industry in South Africa 2020

Full Report

R 1 900.00(ZAR) estimated $105.06 (USD)*

Buy Now +

Industry Landscape

R 1 330.00(ZAR) estimated $ 73.54 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Value Chain	7
2.2.	Geographic Position	8
3.	SIZE OF THE INDUSTRY	9
4.	STATE OF THE INDUSTRY	12
4.1.	Local	12
4.1.1.	Corporate Actions	17
4.1.2.	Regulations	18
4.1.3.	Enterprise Development and Social Economic Development	24
4.2.	Continental	25
4.3.	International	28
5.	INFLUENCING FACTORS	33
5.1.	Coronavirus	33
5.2.	Government Interventions	35
5.3.	Economic Environment	37
5.4.	Labour Resources	39
5.5.	Technology, Research and Development (R&D) and Innovation	40
5.6.	Environmental Concerns	42
5.7.	Drug Abuse	42
5.8.	Substandard Products	43
6.	COMPETITION	43
6.1.	Barriers to Entry	45
7.	SWOT ANALYSIS	46
8.	OUTLOOK	47
9.	INDUSTRY ASSOCIATIONS	48
10.	REFERENCES	49
10.1.	Publications	49
10.2.	Websites	50
	APPENDIX 1	52
	Summary of Notable Players	52
	COMPANY PROFILES	64
	ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD	64
	ACINO HEALTHCARE GROUP (PTY) LTD	66
	ADCOCK INGRAM HOLDINGS LTD	69
	AFRICAN MEDICINES (PTY) LTD	74
	AFRIPLEX (PTY) LTD	76
	AIM AFRICA	79
	ALPHA PHARM (PTY) LTD	81
	AMKA PRODUCTS (PTY) LTD	83
	AMWAY SOUTH AFRICA (PTY) LTD	86
	ASCENDIS HEALTH LTD	88
	ASPEN PHARMACARE HOLDINGS LTD	94
	ASTELLAS PHARMA (PTY) LTD	100
	ASTRAZENECA PHARMACEUTICALS (PTY) LTD	102
	AUROBINDO PHARMA (PTY) LTD	104
	AUSTELL PHARMACEUTICALS (PTY) LTD	106
	B BRAUN MEDICAL (PTY) LTD	108
	BARRS PHARMACEUTICALS INDUSTRIES (PTY) LTD	111
	BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD	113
	BAYER (PTY) LTD	115
	BECTON DICKINSON (PTY) LTD	118
	BIO EARTH MANUFACTURING (PTY) LTD	120
	BIOCLONES (PTY) LTD	122
	BIOLOGICALS AND VACCINES INSTITUTE OF SOUTHERN AFRICA (PTY) LTD (THE)	124
	BITEK INDUSTRIES (PTY) LTD	126
	BRANSON CHEMICALS (PTY) LTD	128
	CALIFORNIA PHARMACEUTICALS (PTY) LTD	130
	CAPRICHEM (PTY) LTD	132
	CHEMICAL CONVERTORS (PTY) LTD	135
	CHEMTRON HOLDINGS (PTY) LTD	136
	CIPLA MEDPRO SOUTH AFRICA (PTY) LTD	137
	COLUMBIA PHARMACEUTICALS (PTY) LTD	141
	COMED HEALTH (PTY) LTD	143
	DEON SCHOEMAN CC	145
	DIS-CHEM PHARMACIES LTD	147
	DR REDDY\'S LABORATORIES (PTY) LTD	157
	DYNACHEM (PTY) LTD	159
	ECOLAB (PTY) LTD	161
	ELI LILLY (SA) (PTY) LTD	163
	EVOHEALTH (PTY) LTD	165
	FERRING (PTY) LTD	167
	FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD	169
	FRESENIUS KABI MANUFACTURING SA (PTY) LTD	172
	FRESENIUS KABI SOUTH AFRICA (PTY) LTD	174
	G M PHARMACEUTICALS (PTY) LTD	177
	GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD	179
	GLENMARK PHARMACEUTICALS SOUTH AFRICA (PTY) LTD	182
	GULF DRUG COMPANY (PTY) LTD	184
	H H DURRHEIM (PTY) LTD	186
	HERBA ZONE (PTY) LTD	188
	HERBALIFE INTERNATIONAL SOUTH AFRICA LTD	190
	HERSOL MANUFACTURING LABORATORIES (PTY) LTD	192
	HYMED (PTY) LTD	194
	IMBC INVESTMENT (PTY) LTD	196
	IMVULA HEALTHCARE LOGISTICS (PTY) LTD	198
	INFECTION PROTECTION PRODUCTS (PTY) LTD	200
	INGELHEIM PHARMACEUTICALS (PTY) LTD	202
	ISZIPHARM PHARMACEUTICAL DISTRIBUTORS (PTY) LTD	204
	JOE SOAP CC	206
	JOHNSON AND JOHNSON (PTY) LTD	208
	KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD	210
	KEVALI CHEMICAL GROUP (PTY) LTD	212
	LAKATO (PTY) LTD	214
	MEDICHEM (PTY) LTD	216
	MEGA MAGIC CC	217
	MERCK (PTY) LTD	219
	MSD (PTY) LTD	221
	NATIONAL BIOPRODUCTS INSTITUTE	223
	NATIVA (PTY) LTD	225
	NEOLIFE INTERNATIONAL (PTY) LTD	227
	NESTLE (SOUTH AFRICA) (PTY) LTD	229
	NETCARE PHARMACIES (PTY) LTD	233
	NETCARE PHARMACIES 2 (PTY) LTD	235
	NEW CLICKS SOUTH AFRICA (PTY) LTD	237
	NKUNZI PHARMACEUTICALS (PTY) LTD	240
	NOVARTIS SOUTH AFRICA (PTY) LTD	242
	NUTRITIONAL HOLDINGS LTD	245
	OMNIA HOLDINGS LTD	249
	P AND G SOUTH AFRICAN TRADING (PTY) LTD	253
	PARCEVAL (PTY) LTD	255
	PFIZER LABORATORIES (PTY) LTD	257
	PHARMA DYNAMICS (PTY) LTD	260
	PHARMACEUTICAL ENTERPRISES (PTY) LTD	262
	PHARMACY DIRECT (PTY) LTD	264
	PHARMAFORCE (PTY) LTD	266
	PHARMED PHARMACEUTICALS (PTY) LTD	268
	PICK N PAY STORES LTD	271
	PLATCHEM (PTY) LTD	275
	PRIME CLEANING SUPPLIERS (PTY) LTD	277
	RANBAXY (S A) (PTY) LTD	279
	RANBAXY PHARMACEUTICALS (PTY) LTD	281
	RECKITT BENCKISER PHARMACEUTICALS (PTY) LTD	283
	RICHBAY CHEMICALS (PTY) LTD	285
	ROCHE PRODUCTS (PTY) LTD	287
	S A F I C (PTY) LTD	290
	S A NATURAL PRODUCTS (PTY) LTD	292
	S BUYS (PTY) LTD	294
	SAFARMEX (PTY) LTD	297
	SAFETY CHEMICALS (PTY) LTD	299
	SANDOZ SOUTH AFRICA (PTY) LTD	300
	SANOFI INDUSTRIES SOUTH AFRICA (PTY) LTD	302
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	304
	SHOPRITE HOLDINGS LTD	307
	SISONKE PARTNERSHIP (THE)	312
	SOLGAR SOUTH AFRICA (PTY) LTD	314
	SONKE PHARMACEUTICALS (PTY) LTD	316
	SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE)	318
	SPAR GROUP LTD (THE)	322
	SPECIALISED MAINTENANCE PRODUCTS (PTY) LTD	328
	SPECPHARM HOLDINGS (PTY) LTD	329
	SPECTANK (PTY) LTD	331
	TEVO (PTY) LTD	333
	TIGER BRANDS LTD	335
	TOPMED HEALTH CARE DISTRIBUTORS (PTY) LTD	340
	TOUCHLESS GERM CONTROL WESTERN CAPE CC	342
	TRANSPHARM (PTY) LTD	343
	UNILEVER SOUTH AFRICA (PTY) LTD	345
	VITAL HEALTH FOODS (PTY) LTD	348
	WACO AFRICA (PTY) LTD	350
	WELLNESS WAREHOUSE (PTY) LTD	354
	WOOLWORTHS HOLDINGS LTD	357
	XIXIA PHARMACEUTICALS (PTY) LTD	361

Introduction

This report focuses on the pharmaceutical sector, which researches, develops, markets and distributes drugs, as part of the wider healthcare system. The industry is valued at R50bn at manufacturers’ exit price and R68bn using retail sales. The challenge facing the industry is expanding access to and affordability of drugs, on the one hand and growing South Africa’s drug manufacturing capacity on the other. The sector seeks to meet this challenge in the context of implementation of the National Health Insurance (NHI) and rapid technological developments.

Strengths

• Investments in capabilities to conduct clinical trials, secondary and tertiary manufacturing.
• Many different pharmaceutical companies operating in specialised markets.
• South Africa has a high demand for pharmaceutical products.

Weaknesses

• Dependence on imported active pharmaceutical ingredients and pharmaceuticals.
• Skills shortages remain high, with 12,000 pharmacists needed to meet the international benchmarks.
• Uncertainty over the implementation of National Health Insurance.

Opportunities

• Export into growing markets in Africa.
• Improvements in regulatory environment with the South African Health Products Regulatory Authority offering an improved service.
• Intellectual property landscape supportive of more affordable drugs and local manufacturing.
• Local manufacturing capabilities can be leveraged to serve growing market demand in the rest of Africa and globally.

Threats

• Continued closures of independent pharmacies.
• Debt in larger companies may limit expansion and may result in the closure of units or even entire businesses.
• Increasing regulatory costs.
• Low economic growth and currency volatility.

Outlook

The outlook for the pharmaceutical industry in South Africa is challenging. Since 2017, high debt in major companies has necessitated restructuring and the sale of businesses, and this process is likely to continue. Government support for pharmaceutical manufacturers, price setting for medications and investments in special economic zones represents an opportunity for the growth of local manufacturing capacity, although this is contingent on government and the private sector meeting their commitments. In providing support, government is hoping to grow local manufacture of drugs and bring down the cost of medicines. The changes to the intellectual property regime, vigilance of the Competition Commission and activism in civil society continue to point to a framework that potentially supports a reduction in drug prices and builds local manufacturing capacity.

The Pharmaceutical Industry in South Africa 2019

Full Report

R 1 900.00(ZAR) estimated $105.06 (USD)*

Buy Now +

Industry Landscape

R 1 330.00(ZAR) estimated $ 73.54 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Supply Chain	4
2.2.	Geographic Position	5
3.	SIZE OF THE INDUSTRY	5
4.	STATE OF THE INDUSTRY	6
4.1.	Local	6
4.1.1.	Corporate Actions	11
4.1.2.	Regulations	12
4.1.3.	Enterprise Development and Social Economic Development	14
4.2.	Continental	15
4.3.	International	15
5.	INFLUENCING FACTORS	17
5.1.	Economic Environment	17
5.2.	Labour Resources	19
5.3.	Technology, Research and Development (R&D) and Innovation	22
5.4.	Environmental Concerns	22
6.	COMPETITION	23
6.1.	Barriers to Entry	25
7.	SWOT ANALYSIS	25
8.	OUTLOOK	26
9.	INDUSTRY ASSOCIATIONS	26
10.	REFERENCES	27
10.1.	Publications	27
10.2.	Websites	28
	APPENDIX 1	30
	Summary of Notable Players	30
	COMPANY PROFILES	41
	ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD	41
	ACINO HEALTHCARE GROUP (PTY) LTD	43
	ADCOCK INGRAM HOLDINGS LTD	45
	AFRICAN MEDICINES (PTY) LTD	50
	AFRIPLEX (PTY) LTD	52
	AIM AFRICA	55
	ALPHA PHARM (KZN) (PTY) LTD	57
	ALPHA PHARM (PTY) LTD	59
	ALPHA PHARM EAST CAPE (PTY) LTD	61
	AMWAY SOUTH AFRICA (PTY) LTD	63
	ASCENDIS HEALTH LTD	66
	ASPEN PHARMACARE HOLDINGS LTD	73
	ASTELLAS PHARMA (PTY) LTD	79
	ASTRAZENECA PHARMACEUTICALS (PTY) LTD	81
	AUROBINDO PHARMA (PTY) LTD	83
	AUSTELL LABORATORIES (PTY) LTD	85
	B BRAUN MEDICAL (PTY) LTD	87
	BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD	90
	BAYER (PTY) LTD	92
	BECTON DICKINSON (PTY) LTD	95
	BIOCLONES (PTY) LTD	97
	BIOFORCE SOUTH AFRICA (PTY) LTD	99
	CALIFORNIA PHARMACEUTICALS (PTY) LTD	101
	CIPLA MEDPRO SOUTH AFRICA (PTY) LTD	103
	COLUMBIA PHARMACEUTICALS (PTY) LTD	107
	COMED HEALTH (PTY) LTD	109
	DEON SCHOEMAN CC	111
	DIS-CHEM PHARMACIES LTD	113
	DR REDDY\'S LABORATORIES (PTY) LTD	122
	ELI LILLY (SA) (PTY) LTD	124
	FERRING (PTY) LTD	126
	FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD	128
	FRESENIUS KABI MANUFACTURING SA (PTY) LTD	131
	FRESENIUS KABI SOUTH AFRICA (PTY) LTD	133
	G M PHARMACEUTICALS (PTY) LTD	136
	GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD	138
	GULF DRUG COMPANY (PTY) LTD	141
	H H DURRHEIM (PTY) LTD	143
	HERBA ZONE (PTY) LTD	145
	HERBALIFE INTERNATIONAL SOUTH AFRICA LTD	147
	HERSOL MANUFACTURING LABORATORIES (PTY) LTD	149
	IMBC INVESTMENT (PTY) LTD	151
	IMVULA HEALTHCARE LOGISTICS (PTY) LTD	153
	INGELHEIM PHARMACEUTICALS (PTY) LTD	156
	JOHNSON AND JOHNSON (PTY) LTD	158
	KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD	160
	LAKATO (PTY) LTD	162
	MERCK (PTY) LTD	164
	MSD (PTY) LTD	166
	NATIONAL BIOPRODUCTS INSTITUTE	168
	NATIVA (PTY) LTD	170
	NEOLIFE INTERNATIONAL (PTY) LTD	172
	NESTLE (SOUTH AFRICA) (PTY) LTD	174
	NETCARE PHARMACIES (PTY) LTD	178
	NETCARE PHARMACIES 2 (PTY) LTD	180
	NEW CLICKS SOUTH AFRICA (PTY) LTD	182
	NKUNZI PHARMACEUTICALS (PTY) LTD	185
	NOVARTIS SOUTH AFRICA (PTY) LTD	187
	NUTRITIONAL HOLDINGS LTD	190
	OMNIA HOLDINGS LTD	193
	P AND G SOUTH AFRICAN TRADING (PTY) LTD	197
	PARCEVAL (PTY) LTD	199
	PFIZER LABORATORIES (PTY) LTD	201
	PHARMA DYNAMICS (PTY) LTD	204
	PHARMACEUTICAL ENTERPRISES (PTY) LTD	206
	PHARMACY DIRECT (PTY) LTD	208
	PHARMED PHARMACEUTICALS (PTY) LTD	210
	PICK N PAY STORES LTD	213
	RANBAXY (S A) (PTY) LTD	218
	RANBAXY PHARMACEUTICALS (PTY) LTD	220
	ROCHE PRODUCTS (PTY) LTD	222
	S A NATURAL PRODUCTS (PTY) LTD	225
	S BUYS (PTY) LTD	227
	SANDOZ SOUTH AFRICA (PTY) LTD	230
	SANOFI INDUSTRIES SOUTH AFRICA (PTY) LTD	233
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	235
	SHOPRITE HOLDINGS LTD	238
	SISONKE PARTNERSHIP (THE)	242
	SOLGAR SOUTH AFRICA (PTY) LTD	244
	SONKE PHARMACEUTICALS (PTY) LTD	246
	SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE)	248
	SPAR GROUP LTD (THE)	252
	SPECPHARM HOLDINGS (PTY) LTD	257
	TIGER BRANDS LTD	259
	TRANSPHARM (PTY) LTD	264
	VITAL HEALTH FOODS (PTY) LTD	266
	WELLNESS WAREHOUSE (PTY) LTD	268
	XIXIA PHARMACEUTICALS (PTY) LTD	271
	ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD	273

Report Coverage

The detailed report on the Pharmaceutical industry focuses on developments in the South African manufacturing and retail sectors during 2016 and 2017. The report profiles 88 companies including newcomer Inicio, which recently secured a licensing agreement with German firm Fluxpharm. The agreement is a key step towards possible domestic production of active pharmaceutical ingredients (APIs) for HIV/AIDS drugs, which locally-based pharmaceutical manufacturers currently import from China and India. If this is successful, South Africa will have its first black-owned pharmaceutical company. State-owned pharmaceutical manufacturer Ketlaphela has yet to begin production of APIs. Also profiled are three companies that have been investigated by the Competition Commission in relation to the supply of various cancer medicines, Pfizer, Aspen and Roche and its US-based biotechnology company, Genentech.

Introduction

This report focuses on developments in the South African pharmaceutical industry during 2016 and 2017. The pharmaceutical industry provides the vital service of providing medication and was valued at R42.6bn in 2016. The most important challenges facing the industry are tensions between improving access to affordable medicines on the one hand, and growing the manufacturing of pharmaceuticals on the other. Other factors influencing the sector include the introduction of the National Health Insurance (NHI), significant changes in technologies to manufacture drugs and the emergence of the use of cannabis and other alternative healing methods.

Strengths

• Improving levels of local manufacturing capacity.
• Investments in capabilities to conduct clinical trials, secondary and tertiary manufacturing.
• Many different pharmaceutical companies operating in specialised markets.
• South Africa has a high demand for pharmaceutical products.

Weaknesses

• Dependence on imported APIs and pharmaceuticals.
• Single Exit Price (SEP) mechanism means manufacturers are pressurised as far as pricing is concerned.
• Skills shortages remain high, with 12,000 pharmacists needed to meet international benchmarks.

Opportunities

• Export into growing markets in Africa.
• Improvements in regulatory environment with the launch of the South African Health Products Regulatory Authority (SAHPRA).
• Improvements in the Intellectual Property (IP) landscape.
• Local manufacturing capabilities can be leveraged to serve growing market demand in the rest of Africa and globally.
• The establishment of API manufacturing sites.
• The state pharmaceutical company, Ketlaphela, could reduce prices and support research once it is operational.

Threats

• Continued closures of independent pharmacies.
• Increasing regulatory costs.
• Low economic growth and currency volatility.
• The legalisation of cannabis as a natural medication.

Outlook

Growth in the pharmaceutical industry is likely to continue, but at a slower pace than experienced over the last five years. Role players believe that the South African pharmaceutical industry will continue to experience major changes mainly in meeting the objectives of providing affordable drugs and at the same time growing manufacturing capacity. Reaching these objectives will prove difficult because of the low levels of economic growth, with stakeholders expressing concern regarding the impact this will have on government resources in general, and specifically on the implementation of the NHI. The interaction between an organised civil society lobbying for affordable drugs, and an organised established pharmaceutical sector seeking to protect its patent laws, is expected to play a significant role in determining the future of the pharmaceutical industry in South Africa.

The Pharmaceutical Industry in South Africa 2017

Full Report

R 1 900.00(ZAR) estimated $105.06 (USD)*

Buy Now +

Industry Landscape

R 1 330.00(ZAR) estimated $ 73.54 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Value Chain	4
2.2.	Geographic Position	5
3.	SIZE OF THE INDUSTRY	6
4.	STATE OF THE INDUSTRY	17
4.1.	Local	17
4.1.1.	Corporate Actions	20
4.1.2.	Regulations	21
4.1.3.	Enterprise Development and Social Economic Development	24
4.2.	Continental	25
4.3.	International	26
5.	INFLUENCING FACTORS	28
5.1.	Economic Environment	28
5.2.	Labour	29
5.3.	Technology, Research and Development (R&D) and Innovation	31
5.4.	Environmental Concerns	31
6.	COMPETITION	32
6.1.	Barriers to Entry	34
7.	SWOT ANALYSIS	34
8.	OUTLOOK	35
9.	INDUSTRY ASSOCIATIONS	36
10.	REFERENCES	37
10.1.	Publications	37
10.2.	Websites	37
	COMPANY PROFILES	38
	ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD	38
	ADCOCK INGRAM HOLDINGS LTD	40
	AFRICAN MEDICINES (PTY) LTD	45
	AFRIPLEX (PTY) LTD	47
	AIM AFRICA	50
	ALPHA PHARM (KZN) (PTY) LTD	52
	ALPHA PHARM (PTY) LTD	54
	ALPHA PHARM EAST CAPE (PTY) LTD	56
	AMWAY SOUTH AFRICA (PTY) LTD	58
	ASCENDIS HEALTH LTD	60
	ASPEN PHARMACARE HOLDINGS LTD	67
	ASTELLAS PHARMA (PTY) LTD	72
	ASTRAZENECA PHARMACEUTICALS (PTY) LTD	74
	AUROBINDO PHARMA (PTY) LTD	76
	AUSTELL LABORATORIES (PTY) LTD	78
	B BRAUN MEDICAL (PTY) LTD	80
	BAXTER HEALTHCARE SOUTH AFRICA (PTY) LTD	83
	BAYER (PTY) LTD	85
	BECTON DICKINSON (PTY) LTD	88
	BIOCLONES (PTY) LTD	90
	CALIFORNIA PHARMACEUTICALS (PTY) LTD	92
	CIPLA MEDPRO SOUTH AFRICA (PTY) LTD	94
	COLUMBIA PHARMACEUTICALS (PTY) LTD	98
	COMED HEALTH (PTY) LTD	100
	DEON SCHOEMAN CC	102
	DIS-CHEM PHARMACIES LTD	104
	DR REDDY\'S LABORATORIES (PTY) LTD	113
	ELI LILLY (SA) (PTY) LTD	115
	FERRING (PTY) LTD	117
	FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD	119
	FRESENIUS KABI MANUFACTURING SA (PTY) LTD	122
	FRESENIUS KABI SOUTH AFRICA (PTY) LTD	124
	G M PHARMACEUTICALS (PTY) LTD	127
	GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD	129
	GULF DRUG COMPANY (PTY) LTD	132
	H H DURRHEIM (PTY) LTD	134
	HERBA ZONE (PTY) LTD	136
	HERBALIFE INTERNATIONAL SOUTH AFRICA LTD	138
	HERSOL MANUFACTURING LABORATORIES (PTY) LTD	140
	IMBC INVESTMENT (PTY) LTD	142
	IMVULA HEALTHCARE LOGISTICS (PTY) LTD	144
	INGELHEIM PHARMACEUTICALS (PTY) LTD	146
	JOHNSON AND JOHNSON (PTY) LTD	148
	KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD	151
	LAKATO (PTY) LTD	153
	LITHA HEALTHCARE GROUP (PTY) LTD	155
	MERCK (PTY) LTD	157
	MSD (PTY) LTD	159
	NATIONAL BIOPRODUCTS INSTITUTE	161
	NATIVA (PTY) LTD	163
	NEOLIFE INTERNATIONAL (PTY) LTD	165
	NESTLE (SOUTH AFRICA) (PTY) LTD	167
	NETCARE PHARMACIES 2 (PTY) LTD	171
	NEW CLICKS SOUTH AFRICA (PTY) LTD	173
	NKUNZI PHARMACEUTICALS (PTY) LTD	176
	NOVARTIS SOUTH AFRICA (PTY) LTD	178
	NUTRI PHARMA SOLUTIONS (PTY) LTD	180
	NUTRITIONAL HOLDINGS LTD	182
	OMNIA HOLDINGS LTD	185
	PARCEVAL (PTY) LTD	189
	PFIZER LABORATORIES (PTY) LTD	191
	PHARMA DYNAMICS (PTY) LTD	194
	PHARMACEUTICAL ENTERPRISES (PTY) LTD	197
	PHARMACY DIRECT (PTY) LTD	199
	PHARMED PHARMACEUTICALS (PTY) LTD	201
	PICK N PAY STORES LTD	204
	PROCTER AND GAMBLE SA (PTY) LTD	209
	RANBAXY (SA) (PTY) LTD	211
	RANBAXY PHARMACEUTICALS (PTY) LTD	213
	ROCHE PRODUCTS (PTY) LTD	215
	S A NATURAL PRODUCTS (PTY) LTD	218
	S BUYS (PTY) LTD	220
	SANDOZ SOUTH AFRICA (PTY) LTD	223
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	226
	SHOPRITE HOLDINGS LTD	229
	SISONKE PARTNERSHIP (THE)	233
	SOLGAR SOUTH AFRICA (PTY) LTD	235
	SONKE PHARMACEUTICALS (PTY) LTD	237
	SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE)	239
	SPAR GROUP LTD (THE)	242
	SPECPHARM HOLDINGS (PTY) LTD	247
	TIGER BRANDS LTD	249
	TRANSPHARM (PTY) LTD	254
	VITAL HEALTH FOODS (PTY) LTD	256
	WELLNESS WAREHOUSE (PTY) LTD	259
	XIXIA PHARMACEUTICALS (PTY) LTD	262
	ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD	264
	ZENTIVA SOUTH AFRICA (PTY) LTD	266

Report Coverage

The report on the Pharmaceutical industry describes merger and acquisition activity, the latest regulatory developments and discusses factors influencing the success of the sector. The report profiles 90 companies ranging from South Africa’s two largest pharmaceutical manufacturers, Aspen Pharmacare and Adcock Ingram to newcomers to the Top 20, Mylan and Valeant Pharmaceuticals which both have less than 2% share of the market. Also profiled are African Medicines (Pty) Ltd t/a Pakmed Self Medication and GNLD International (Pty) Ltd, companies that use the services of contract manufacturers such as Wrapsa. Large national retailers with in-house pharmacies like Clicks and Pick ‘n Pay, which have proved to be fierce competition to traditional independent and community pharmacies, are also profiled in this report.

Introduction

This report focuses on developments in the South African pharmaceutical industry during 2015 and 2016. This vital industry, which incorporates research and development, manufacture, import, distribution, wholesale and retail of pharmaceutical products, was valued at R39.3bn in 2015, with total counting units reaching 51.9 billion. Although pharmaceutical companies acknowledge that their primary responsibility is to ensure access to affordable healthcare for consumers, some stakeholders, especially those campaigning for a change in the patent laws and in the private healthcare sector, believe companies continue to place large profits before improved health.

Strengths

• Active government support for industrialisation efforts.
• Strong and active civil society organisations focused on improving access to and affordability of drugs.
• There is a strong pharmaceutical R&D and clinical trial sector.
• Well established local industry, with strong international presence.

Weaknesses

• Currently, dependence on MCC and a long registration period for pharmaceutical products.
• Dependence on imported APIs and pharmaceuticals.
• Patent system for drugs consistently challenged due to high cost of pharmaceuticals.
• SEP regulation which does not allow manufacturers to increase prices to adjust for higher input costs.
• Shortage of pharmacists and pharmacist assistants.

Opportunities

• Export into growing markets in Africa.
• Growth of generic sector.
• Improvements in procurement systems for public sector drug provision.
• Improvements in regulatory environment with the imminent launch of the South African Health Products Regulatory Authority.
• R&D, particularly the “Farmer to Pharma grand challenge.”
• Well-functioning state-run pharmaceutical company could reduce prices and potentially support research.

Threats

• Continued closures of independent pharmacies.
• Low economic growth and currency volatility.
• Regulatory costs are high for alternative and complementary medicines.

Outlook

The South African pharmaceutical industry is expected to experience significant changes over the next few years. These changes include the introduction of a new regulator, the South African Health Products Regulatory Authority (SAHPRA), the implementation of the National Health Insurance and continued focus on industrialisation efforts in the pharmaceutical industry. These developments coupled with a strong civil society advocacy for changing the patent laws, are likely to create an environment that is ripe for change. These changes potentially provide South Africa with a basis to grow the pharmaceutical industry and at the same time reduce the costs of drugs. The growth of the generics segment of the market in particular is likely to provide a basis for growing manufacturing capacity, and at the same time increasing access to life-savings drugs. Stakeholders assert, however, that industry and government will need to cooperate on these matters, as the reforms being undertaken are large and carry with them significant challenges.

The Pharmaceutical Industry in South Africa 2016

Full Report

R 1 900.00(ZAR) estimated $105.06 (USD)*

Buy Now +

Industry Landscape

R 1 330.00(ZAR) estimated $ 73.54 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2014-05-30

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Value Chain	2
2.2.	Geographic Position	4
3.	SIZE OF THE INDUSTRY	4
4.	STATE OF THE INDUSTRY	16
4.1.	Local	16
4.1.1.	Corporate Actions	18
4.1.2.	Regulations	20
4.1.3.	Enterprise Development and Social Economic Development	23
4.2.	Continental	23
4.3.	International	25
5.	INFLUENCING FACTORS	27
5.1.	Changes to the Regulatory Environment	27
5.2.	Economic Environment	27
5.3.	Government Initiatives	28
5.4.	Technology, Research and Development (R&D) and Innovation	29
5.5.	Labour	29
6.	COMPETITION	32
6.1.	Barriers to Entry	33
7.	SWOT ANALYSIS	34
8.	OUTLOOK	35
9.	INDUSTRY ASSOCIATIONS	35
10.	REFERENCES	36
10.1.	Publications	36
10.2.	Websites	36
	APPENDIX 1	38
	List of Mergers and Acquisitions in the Global Pharmaceutical Industry in 2015 and 2016	38
	COMPANY PROFILES – MANUFACTURE AND WHOLESALE OF PHARMACEUTICALS AND NUTRICEUTICALS	50
	ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD	50
	ADCOCK INGRAM HOLDINGS LTD	52
	AFRICAN MEDICINES (PTY) LTD	57
	AFRIPLEX (PTY) LTD	59
	AIM AFRICA	62
	ALPHA PHARM (KZN) (PTY) LTD	64
	ALPHA PHARM (PTY) LTD	66
	ALPHA PHARM EAST CAPE (PTY) LTD	68
	AMWAY SOUTH AFRICA (PTY) LTD	70
	ASCENDIS HEALTH LTD	72
	ASPEN PHARMACARE HOLDINGS LTD	78
	ASTELLAS PHARMA (PTY) LTD	82
	ASTRAZENECA PHARMACEUTICALS (PTY) LTD	84
	AUROBINDO PHARMA (PTY) LTD	87
	AUSTELL LABORATORIES (PTY) LTD	89
	B BRAUN MEDICAL (PTY) LTD	91
	BAYER (PTY) LTD	95
	BECTON DICKINSON (PTY) LTD	98
	BIOCLONES (PTY) LTD	100
	CALIFORNIA PHARMACEUTICALS (PTY) LTD	102
	CIPLA MEDPRO SOUTH AFRICA (PTY) LTD	104
	COLUMBIA PHARMACEUTICALS (PTY) LTD	108
	COMED HEALTH (PTY) LTD	110
	CREST CHEMICALS (PTY) LTD	112
	DB FINE CHEMICALS (PTY) LTD	114
	DEON SCHOEMAN CC	116
	DIS-CHEM PHARMACIES (PTY) LTD	118
	DR REDDY\'S LABORATORIES (PTY) LTD	123
	ELI LILLY (SA) (PTY) LTD	125
	FERRING (PTY) LTD	127
	FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD	129
	FRESENIUS KABI MANUFACTURING SA (PTY) LTD	132
	G M PHARMACEUTICALS (PTY) LTD	134
	GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD	136
	GNLD INTERNATIONAL (PTY) LTD	138
	GULF DRUG COMPANY (PTY) LTD	140
	H H DURRHEIM (PTY) LTD	142
	HERBA ZONE (PTY) LTD	144
	HERBALIFE INTERNATIONAL SOUTH AFRICA LTD	146
	HERSOL MANUFACTURING LABORATORIES (PTY) LTD	148
	IMBC INVESTMENT (PTY) LTD	150
	IMVULA HEALTHCARE LOGISTICS (PTY) LTD	152
	INGELHEIM PHARMACEUTICALS (PTY) LTD	155
	JOHNSON AND JOHNSON (PTY) LTD	157
	KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD	160
	LAKATO (PTY) LTD	162
	LITHA HEALTHCARE GROUP (PTY) LTD	164
	MERCK (PTY) LTD	167
	MSD (PTY) LTD	169
	NATIONAL BIOPRODUCTS INSTITUTE	171
	NATIVA (PTY) LTD	173
	NESTLE (SOUTH AFRICA) (PTY) LTD	175
	NEW CLICKS SOUTH AFRICA (PTY) LTD	178
	NKUNZI PHARMACEUTICALS (PTY) LTD	181
	NOVARTIS SOUTH AFRICA (PTY) LTD	183
	NUTRI PHARMA SOLUTIONS (PTY) LTD	186
	NUTRITIONAL HOLDINGS LTD	188
	OMNIA HOLDINGS LTD	191
	PARCEVAL (PTY) LTD	195
	PFIZER LABORATORIES (PTY) LTD	197
	PHARMA DYNAMICS (PTY) LTD	200
	PHARMACEUTICAL ENTERPRISES (PTY) LTD	202
	PHARMACY DIRECT (PTY) LTD	204
	PHARMED PHARMACEUTICALS (PTY) LTD	206
	PROCTER AND GAMBLE SA (PTY) LTD	209
	RANBAXY (SA) (PTY) LTD	211
	ROCHE PRODUCTS (PTY) LTD	213
	S A NATURAL PRODUCTS (PTY) LTD	216
	S BUYS (PTY) LTD	218
	SANDOZ SOUTH AFRICA (PTY) LTD	220
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	222
	SAVANNAH FINE CHEMICALS (PTY) LTD	224
	SHOPRITE HOLDINGS LTD	226
	SISONKE PARTNERSHIP (THE)	232
	SK CHEMTRADE SERVICES (PTY) LTD	234
	SOLGAR SOUTH AFRICA (PTY) LTD	236
	SONKE PHARMACEUTICALS (PTY) LTD	238
	SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE)	240
	SPECPHARM HOLDINGS (PTY) LTD	243
	TIGER BRANDS LTD	245
	TRANSPHARM (PTY) LTD	250
	VITAL HEALTH FOODS (PTY) LTD	252
	WARREN CHEM SPECIALITIES (PTY) LTD	255
	XIXIA PHARMACEUTICALS (PTY) LTD	257
	ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD	259
	ZENTIVA SOUTH AFRICA (PTY) LTD	261
	COMPANY PROFILES - RETAIL OF PHARMACEUTICALS	263
	AIM AFRICA	263
	CLICKS RETAILERS (PTY) LTD	265
	DEON SCHOEMAN CC	267
	DIS-CHEM PHARMACIES (PTY) LTD	269
	G M PHARMACEUTICALS (PTY) LTD	275
	NATIVA (PTY) LTD	277
	NETCARE PHARMACIES 2 (PTY) LTD	279
	NEW CLICKS SOUTH AFRICA (PTY) LTD	281
	PICK N PAY STORES LTD	284
	SANDOZ SOUTH AFRICA (PTY) LTD	288
	SHOPRITE HOLDINGS LTD	290
	SPAR GROUP LTD (THE)	296
	WELLNESS WAREHOUSE (PTY) LTD	301

Introduction

This report focuses on the South African pharmaceutical industry. The manufacturing industry generated R32.4bn while the retail industry in pharmaceutical and medical goods, cosmetics and toiletries reached R49.96bn in 2013. Generic drug use is increasing rapidly, driven by government’s goal for more affordable pharmaceuticals in South Africa. The domestic manufacturing industry is relatively small and 65% of pharmaceuticals are imported. Medical aids have increasing power, shaping consumer use of pharmaceuticals to the advantage of corporate pharmacies, which have been able to grow their share of the market to 35.5% since 2004.

Strengths

• Pharmaceuticals are a vital part of the healthcare system.
• The two leading pharmaceutical companies are locallybased,\ngeneric manufacturers.
• There are a variety of different types of pharmaceutical\ncompanies present in the country.
• There is a strong pharmaceutical R&D and clinical trial sector.

Weaknesses

• Critical skill shortage of pharmacists and pharmacist\nassistants.
• Dependence on imported APIs and pharmaceuticals.
• Dependence on MCC and a long registration period for\npharmaceutical products.
• SEP regulation which does not allow manufacturers to increase prices to adjust for higher input costs

Opportunities

• Establishment of SAHPRA which is to replace the MCC.
• Increasing roll-out of government tenders for generic drugs\nto treat HIV/AIDS and TB.
• NHI through which a large number of South Africans will be\ngiven access to pharmaceuticals.
• Opportunities for API and pharmaceutical manufacturing\nexist.
• Patent expiry opens the market for the development of\ngenerics.
• Potential for generic manufacturers to utilise their spare\ncapacity to produce products to export globally.
• Potential for increased exports to African countries.

Threats

• Continuing delays in the registration of pharmaceutical product at the MCC.
• Deteriorating economic conditions.
• For community pharmacists, the practice of DSP.
• Increasing number of cheap imports from India and China.
• New regulations for complementary and alternative medicines will mean high costs which may be prohibitive for small companies.
• Rising input costs, especially rising cost of imported APIs.

Outlook

The growth in the global pharmaceutical industry is expected to be between 3% and 6% CAGR, reaching a value of approximately $1.2 trillion in 2016. For the local industry, growth is expected because of increasing government support for the use and manufacture of pharmaceuticals. The future is “very positive from a generic point of view” according to Vivian Frittelli, CEO of the National Association of Pharmaceutical Manufacturers and the generic manufacturing industry is expected to grow by 10% in 2014 and 10% to 12% annually up to 2019. This is because of government’s increasing support for the use of generics for the treatment of HIV/AIDS and TB and the expiry of the patents for a number of originator drugs. \r\n \r\nIn the short term, however, the deteriorating macroeconomic outlook is likely to slow the consumption of pharmaceuticals in the private healthcare and retail pharmaceutical sector and impact on the costs of imported ingredients and products. Manufacturers are therefore likely to look for opportunities outside South Africa to drive volumes and profits.

The Pharmaceutical Industry in South Africa 2014

Full Report

R 1 900.00(ZAR) estimated $105.06 (USD)*

Buy Now +

Industry Landscape

R 1 330.00(ZAR) estimated $ 73.54 (USD)*

Buy Now +

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

R 9 500.00(ZAR) estimated $525.29 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2022-03-08

R 6 500.00(ZAR) estimated $359.41 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2020-12-11

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2019-04-05

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2017-12-08

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

The Pharmaceutical Industry in South Africa 2016-09-12

R 1 900.00(ZAR) estimated $105.06 (USD)*

View Report Add to Cart

[ Close ]

		PAGE
1.	INTRODUCTION	1
2.	DESCRIPTION OF THE INDUSTRY	1
2.1.	Industry Supply Chain	2
3.	SIZE OF THE INDUSTRY	2
4.	STATE OF THE INDUSTRY	17
4.1.	Local	17
4.1.1.	Manufacture and Distribution/Wholesale	17
4.1.2.	Retail	19
4.1.3.	Corporate Actions	19
4.1.4.	Regulations	20
4.1.5.	Black Economic Empowerment	22
4.2.	Continental	22
4.3.	International	24
5.	INFLUENCING FACTORS	24
5.1.	SEP	24
5.2.	Intellectual Property Law	25
5.3.	Slow Registration Process for New Pharmaceuticals	25
5.4.	Medical Aids	25
5.5.	National Health Insurance (NHI)	26
5.6.	Economic Environment	26
5.7.	Disease Burden	26
5.8.	New regulations for Complementary Medicines	26
5.9.	Counterfeit Medicine	26
5.10.	Labour Resources	27
5.11.	Environmental Concerns	27
6.	COMPETITION	28
6.1.	Barriers to Entry	28
6.2.	Research and Development (R&D) and Innovation	28
7.	SWOT ANALYSIS	30
8.	OUTLOOK	30
9.	INDUSTRY ASSOCIATIONS	31
10.	REFERENCES	31
10.1.	Publications	31
10.2.	Websites	32
	ORGANOGRAM 33530	33
	Manufacture of Pharmaceuticals and Nutriceuticals	33
	COMPANY PROFILES	39
	ABBOTT LABORATORIES SOUTH AFRICA (PTY) LTD	39
	ADCOCK INGRAM HEALTHCARE (PTY) LTD	40
	AFRICAN MEDICINES (PTY) LTD	42
	AFRIPLEX (PTY) LTD	43
	AIM AFRICA INC	44
	AMWAY SOUTH AFRICA (PTY) LTD	45
	ASCENDIS HEALTH LTD	46
	ASPEN PHARMACARE HOLDINGS LTD	48
	ASTELLAS PHARMA (PTY) LTD	51
	ASTRAZENECA PHARMACEUTICALS (PTY) LTD	52
	AUROBINDO PHARMA (PTY) LTD	54
	AUSTELL LABORATORIES (PTY) LTD	55
	B BRAUN MEDICAL (PTY) LTD	56
	BAYER (PTY) LTD	58
	BIOCLONES (PTY) LTD	60
	CALIFORNIA PHARMACEUTICALS (PTY) LTD	61
	CHEMPURE (PTY) LTD	62
	CIPLA MEDPRO SOUTH AFRICA (PTY) LTD	63
	CLICKS GROUP LTD	66
	COLUMBIA PHARMACEUTICALS (PTY) LTD	69
	COMED HEALTH (PTY) LTD	70
	COVIDIEN (PTY) LTD	72
	CREST CHEMICALS (PTY) LTD	73
	DB FINE CHEMICALS (PTY) LTD	75
	DEON SCHOEMAN CC	76
	DIS-CHEM CONSOLIDATED (PTY) LTD	77
	DR REDDY\'S LABORATORIES (PTY) LTD	78
	FERRING (PTY) LTD	79
	FOREVER LIVING PRODUCTS SOUTH AFRICA (PTY) LTD	80
	FRESENIUS KABI MANUFACTURING SA (PTY) LTD	82
	GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD	83
	GM PHARMACEUTICALS (PTY) LTD	85
	GNLD INTERNATIONAL (PTY) LTD	86
	GULF DRUG COMPANY (PTY) LTD	87
	HERBA ZONE (PTY) LTD	88
	HERBALIFE INTERNATIONAL SOUTH AFRICA LTD	89
	HERSOL MANUFACTURING LABORATORIES (PTY) LTD	90
	INGELHEIM PHARMACEUTICALS (PTY) LTD	91
	JOHNSON & JOHNSON (PTY) LTD	92
	KELLOGG COMPANY OF SOUTH AFRICA (PTY) LTD	94
	LITHA HEALTHCARE GROUP LTD	95
	MERCK (PTY) LTD	97
	MSD (PTY) LTD	98
	NATIVA (PTY) LTD	99
	NESTLE (SA) (PTY) LTD	100
	NKUNZI PHARMACEUTICALS (PTY) LTD	102
	NOVARTIS SOUTH AFRICA (PTY) LTD	103
	NUTRI PHARMA SOLUTIONS (PTY) LTD	105
	NUTRITIONAL HOLDINGS LTD	106
	OMNIA HOLDINGS LTD	108
	PARCEVAL (PTY) LTD	110
	PFIZER LABORATORIES (PTY) LTD	111
	PHARMA DYNAMICS (PTY) LTD	113
	PHARMA NATURA (PTY) LTD	115
	PHARMACEUTICAL ENTERPRISES (PTY) LTD	116
	RANBAXY (SA) (PTY) LTD	117
	REGAL NUTRIENTS (PTY) LTD	119
	ROCHE PRODUCTS (PTY) LTD	120
	SA NATURAL PRODUCTS (PTY) LTD	122
	SANDOZ SOUTH AFRICA (PTY) LTD	123
	SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD	124
	SAVANNAH FINE CHEMICALS (PTY) LTD	126
	SK CHEMTRADE SERVICES (PTY) LTD	127
	SOLGAR SOUTH AFRICA (PTY) LTD	128
	SONKE PHARMACEUTICALS (PTY) LTD	129
	SOUTH AFRICAN NUCLEAR ENERGY CORPORATION SOC LTD (THE)	130
	SPECPHARM HOLDINGS (PTY) LTD	132
	SPORTRON INTERNATIONAL (PTY) LTD	133
	SUNRIDER SOUTH AFRICA (PTY) LTD	134
	SWISSGARDE (PTY) LTD	135
	TIGER BRANDS LTD	136
	VITAL HEALTH FOODS (PTY) LTD	139
	WARREN CHEM SPECIALITIES (PTY) LTD	141
	WINTHROP PHARMACEUTICALS (PTY) LTD	142
	ORGANOGRAM 61394A	143
	Wholesale of Pharmaceuticals	143
	COMPANY PROFILES	145
	ALPHA PHARM (KZN) (PTY) LTD	145
	ALPHA PHARM EAST CAPE (PTY) LTD	146
	ALPHA PHARM WESTERN CAPE LTD	147
	BECTON DICKINSON (PTY) LTD	148
	CHERYL HAWKINS SOLE PROPRIETOR	152
	CLICKS GROUP LTD	153
	DIS-CHEM PHARMACIES (PTY) LTD	156
	ELI LILLY (SA) (PTY) LTD	159
	FREE STATE BUYING ASSOCIATION LTD	160
	HH DURRHEIM (PTY) LTD	161
	IMBC INVESTMENT (PTY) LTD	163
	IMVULA HEALTHCARE LOGISTICS (PTY) LTD	164
	LAKATO (PTY) LTD	166
	NAMPAK PRODUCTS LTD	167
	P&G SOUTH AFRICAN TRADING (PTY) LTD	170
	PHARMACY DIRECT (PTY) LTD	171
	PHARMED PHARMACEUTICALS (PTY) LTD	172
	PREMIER FOODS (PTY) LTD	174
	RTT GROUP (PTY) LTD	176
	SISONKE PARTNERSHIP (THE)	179
	TRANSPHARM (PTY) LTD	181
	UTI SOUTH AFRICA (PTY) LTD	182
	XIXIA PHARMACEUTICALS (PTY) LTD	185
	ZENITH PHARMACEUTICAL DISTRIBUTORS (PTY) LTD	186
	ORGANOGRAM 62310A	187
	Retail of Pharmaceuticals	187
	COMPANY PROFILES	188
	CHRONIC MEDICINE DISPENSARY (PTY) LTD	188
	CLICKS DIRECT MEDICINES (PTY) LTD	189
	CLICKS GROUP LTD	190
	DIS-CHEM PHARMACIES (PTY) LTD	193
	NETCARE PHARMACIES 2 (PTY) LTD	196
	PICK \'N PAY STORES LTD	197
	S BUYS (PTY) LTD	220
	SHOPRITE HOLDINGS LTD	222
	SPAR GROUP LTD (THE)	226
	WELLNESS WAREHOUSE (PTY) LTD	229

pharmaceutical industry south africa

The Pharmaceutical Industry in South Africa 2023

The Pharmaceutical Industry in South Africa 2022

The Pharmaceutical Industry in South Africa 2020

The Pharmaceutical Industry in South Africa 2019

The Pharmaceutical Industry in South Africa 2017

The Pharmaceutical Industry in South Africa 2016

The Pharmaceutical Industry in South Africa 2014

Report Info

Report Coverage

Introduction

Trends

Opportunities

Challenges

Outlook

Full Report Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. Full Industry reports also profile all major players operating in the industry.

Industry Landscape Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. The Overview reports do not include profiles of major players.

Historical Reports

The Pharmaceutical Industry in South Africa 2022-03-08

The Pharmaceutical Industry in South Africa 2020-12-11

The Pharmaceutical Industry in South Africa 2019-04-05

The Pharmaceutical Industry in South Africa 2017-12-08

The Pharmaceutical Industry in South Africa 2016-09-12

The Pharmaceutical Industry in South Africa 2014-05-30

Table of Contents

Report Coverage

Introduction

Strengths

Weaknesses

Opportunities

Threats

Outlook

Full Report Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. Full Industry reports also profile all major players operating in the industry.

Industry Landscape Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. The Overview reports do not include profiles of major players.

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

The Pharmaceutical Industry in South Africa 2020-12-11

The Pharmaceutical Industry in South Africa 2019-04-05

The Pharmaceutical Industry in South Africa 2017-12-08

The Pharmaceutical Industry in South Africa 2016-09-12

The Pharmaceutical Industry in South Africa 2014-05-30

Table of Contents

Report Coverage

Introduction

Strengths

Weaknesses

Opportunities

Threats

Outlook

Full Report Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. Full Industry reports also profile all major players operating in the industry.

Industry Landscape Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. The Overview reports do not include profiles of major players.

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

The Pharmaceutical Industry in South Africa 2022-03-08

The Pharmaceutical Industry in South Africa 2019-04-05

The Pharmaceutical Industry in South Africa 2017-12-08

The Pharmaceutical Industry in South Africa 2016-09-12

The Pharmaceutical Industry in South Africa 2014-05-30

Table of Contents

Introduction

Strengths

Weaknesses

Opportunities

Threats

Outlook

Full Report Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. Full Industry reports also profile all major players operating in the industry.

Industry Landscape Country or Region-specific industry reports on 400 + key industries across the African continent identifying supply chain, influencing factors, SWOT and other key industry drivers. The Overview reports do not include profiles of major players.

Historical Reports

The Pharmaceutical Industry in South Africa 2023-08-23

The Pharmaceutical Industry in South Africa 2022-03-08

The Pharmaceutical Industry in South Africa 2020-12-11

The Pharmaceutical Industry in South Africa 2017-12-08

The Pharmaceutical Industry in South Africa 2016-09-12

The Pharmaceutical Industry in South Africa 2014-05-30

Table of Contents

Report Coverage

Introduction

Strengths

Weaknesses

Opportunities

Full Report

Industry Landscape

Full Report

Industry Landscape

Full Report

Industry Landscape

Full Report

Industry Landscape

Full Report

Industry Landscape

Full Report

Industry Landscape

Full Report

Industry Landscape